Found 29 matching trials
Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
PHASE1The primary objective is to determine if the opioid properties of ketamine ...
Location
Stanford University
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)
PHASE1PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Location
PRA Health Sciences - Early Development Services
Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
PHASE4This study seeks to compare the effectiveness of two medications used to tr...
Location
Yale University School of Medicine
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
NAThe purpose of this protocol is to learn more about impulsive decision maki...
Location
Oregon Health & Science University
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
PHASE1To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 0034543...
Location
Pfizer Investigational Site
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
PHASE1A single dose dose study to assess the pharmacokinetics (PK) of oxycodone, ...
Location
Quotient Sciences
An Investigation of the Effects of Opioid Receptor Blockade on Changes in Self-esteem and Social Attention
NAThe purpose of this study is to explore the effects of endogenous opioids o...
Location
Multiple Locations
Pharmacokinetics Study of ALO-02 and OxyContin
PHASE1To characterize the single- and multiple-dose pharmacokinetics of oxycodone...
Location
Pfizer Investigational Site
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
NAInsulin treatment often causes the blood glucose levels to fall too low. Th...
Location
Yale School of Medicine
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
PHASE3In pilot study now proposed, we plan to randomly assign 60 opioid dependent...
Location
New York State Psychiatric Institute